Author: Will Doss

Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.

A new exhibit at Galter Health Sciences Library and Learning Center showcases the medical experiences of hundreds of Northwestern physicians, nurses, dentists and enlisted men in World War II.

A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.

Founders’ Day welcomes first-year medical students to campus, honors Feinberg’s founders and marks the official start of the academic year.

Northwestern Medicine scientists identified the mechanism that transports important neuroreceptors from sites outside to within the synapse, publishing their findings in Cell Reports.

Scientists have identified a new gene that can inhibit a multi-protein complex, possibly increasing the risk of cancer, according to a new study published in Science Advances.

The Northwestern University Minority Health and Health Disparities Research Training Program, funded by the National Institutes of Health, will provide health disparities research training experiences to minority and other underrepresented students and trainees.

Sheetal Kircher, MD, ’11 GME, is laser-focused on cancer drug distribution and pricing: she spent a year as a health policy fellow at the ASCO and published a paper on the topic in JAMA.

Northwestern Medicine scientists have developed and validated a tool to predict which patients with pre-osteoarthritis are at high risk for developing disability in the future.

Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.